Business
STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer
New Positions Demonstrate Increased Commitment and Focus on Continued Industry Leading Growth LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company
About this update from Staar Surgical Company
[{"type":"text","content":"\nNew Positions Demonstrate Increased Commitment and Focus on Continued Industry Leading Growth\n\n LAKE FOREST, Calif.--(BUSINESS WIRE)--\nSTAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced Warren Foust has been named Chief Operating Officer and Magda Michna, Ph.D., has been named Chief Clinical, Regulatory and Medical Affairs Officer. Both positions will report to STAAR Surgical’s President and CEO, Tom Frinzi.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230329005378/en/Warren Foust, Chief Operating Officer, STAAR Surgical Company (Photo: Business Wire)\n“The addition of two highly regarded ophthalmic leaders to our team exemplifies the success, momentum and opportunity for STAAR as we work with surgeons to expand the market for refractive vision correction with our proprietary EVO ICL lenses to the millions of people seeking visual freedom from contact lenses and glasses,” said Tom Frinzi, President and CEO of STAAR Surgical. “Warren will be integral to advancing our growth objectives, especially in the U.S., including many important aspects of our commercial and manufacturing operations. He is uniquely qualified to work with the U.S. surgeon community given his experience leading one of the world’s premier ophthalmic businesses. Dr. Michna is an important addition to overseeing and advancing our global clinical and regulatory pipeline, as well as adding to the published data supporting the clinical benefits of our lens technologies. My sincere gratitude to Denise McEachern, STAAR’s Global Head of Regulatory Affairs, who is planning to retire after successfully shepherding several STAAR medical devices through the regulatory process and approval. Today, STAAR is a company delivering industry leading growth and with increasing momentum for even greater growth. Our focus remains capturing the tremendous whitespace opportunity in front of us.”\n\nMost recently, Warren Foust served as Worldwide President, Johnson & Johnson Vision, Surgical, since December 2019. At Johnson & Johnson, Warren managed the global surgical business with approximately $1.5 billion in annual sales and 5,000 employees. Prior to Johnson & Johnson Vision, Surgical, Warren served as Worldwide President of Men...